Fundacion Favaloro Para La Docencia e Investigacion Medica Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00664339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

FUNDACION FAVALORO PARA LA DOCENCIA Y LA INVESTIGACION MEDICA

Active Ingredients

Drugs in Phase 4 Trials (1)

fluarix (1 trial)

Drugs in Phase 3 Trials (1)

tanezumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Heart Failure (Phase 4)

Musculoskeletal Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2